Research Compound

GW501516 (Cardarine)

GW 501516 is indexed as a chemical in the cited mouse PPARβ/δ-agonist study. The cited papers concern mice: one separates findings for GW1516 and AICAR in exercise and sedentary models; the other examines genetic PPAR-delta activation without administering GW501516. Neither study establishes human performance, treatment, dosing or safety. We have not matched GW501516 to an entry in the current wholesale price list, so no presentation, price or availability is shown.

Technical Specifications

ClassGW 501516 is indexed as a chemical in the cited mouse PPARβ/δ-agonist study.
Commercial identityNo exact matching SKU exists in the current wholesale price list.
Identity packageBefore ordering, confirm compound name, CAS number, formula, molecular mass, stereochemical or isomeric scope, and LC-MS or NMR identity evidence.
AssayAny purity value must state the analytical method, related-substance scope and whether isomeric impurities are resolved.
Form and vehicleConfirm the supplied form, solvent compatibility and protocol-specific vehicle. Solubility data must refer to the exact material.
HandlingUse batch-specific light, moisture, temperature and solution-stability data.

Preclinical PPAR-delta research

  • PPAR-delta target biology
  • Mouse exercise-adaptation models
  • AMPK and PPAR-delta pathway comparison
  • Muscle-fiber metabolic research
  • Chemical identity and assay development

Wholesale pricing and batch checks

Price and SKU not published

No exact matching SKU exists in the current wholesale price list, so no price, dosage, form or quantity tier is published.

What to check before asking about GW501516

We have not matched GW501516 to a current wholesale-list entry. We cannot issue a product quote until the compound identity, supplied form and analytical package are resolved.

Exact compound identity

Confirm the full chemical identity, CAS number, formula, molecular mass and any stereochemical or isomeric scope. Reject near-name matching.

Analytical evidence

Request LC-MS and, where appropriate, NMR evidence together with the chromatographic assay, related-substance profile, water and residual solvents.

Protocol and safety boundary

Match vehicle, concentration and handling to the laboratory protocol. Do not convert mouse-model findings into human dosing, performance or safety claims.

The two cited studies describe target biology and mouse models. They do not establish human use or clinical efficacy, and they cannot verify material supplied under this name.

Research evidence for GW501516

Narkar et al. (2008). AMPK and PPARδ Agonists Are Exercise Mimetics. Cell. DOI: 10.1016/j.cell.2008.06.051

Study scope: Mouse exercise and sedentary models. The study distinguishes the PPAR-delta agonist GW1516 from the AMPK agonist AICAR and evaluates pathway interactions.

What it supports: Supports a bounded discussion of AMPK and PPAR-delta pathway effects in mouse exercise-adaptation models.

Boundary: The sedentary endurance result must not be automatically attributed to GW501516; compound-specific results must be separated from AICAR. The study does not establish human performance.

Wang et al. (2004). Regulation of Muscle Fiber Type and Running Endurance by PPARδ. PLoS Biology. DOI: 10.1371/journal.pbio.0020294

Study scope: Mice with altered skeletal-muscle PPAR-delta signaling. Genetic PPAR-delta activation; GW501516 was not the experimental intervention establishing the reported phenotype.

What it supports: Supports PPAR-delta target biology, oxidative muscle-fiber regulation and running-endurance phenotypes in mice.

Boundary: The genetic model is not evidence that a supplied GW501516 product reproduces the phenotype, and it is not human efficacy evidence.

Frequently Asked Questions About GW501516

GW 501516 is indexed as a chemical in the cited mouse PPARβ/δ-agonist study. This page does not extend that record into a human performance, treatment, dosing or safety claim.

No. The current wholesale price list has no exact matching SKU, so this page does not publish a dosage, form, numeric price or availability state.

The paper studied both GW1516 and AICAR. Its compound-specific results must be kept separate; the sedentary endurance result must not be reassigned to GW501516 without that distinction.

It shows PPAR-delta biology in a genetic mouse model. It did not establish the phenotype by administering a supplier product labelled GW501516.

No. Both cited papers are mouse studies and do not establish human efficacy, dosing or safety.

Confirm exact chemical identity, CAS number, form, analytical assay, related substances, water, residual solvents, vehicle compatibility and batch-specific handling data.

Ask About GW501516